SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
ArQule, Inc. (ARQL)
An SI Board Since April 2003
Posts SubjectMarks Bans Symbol
545 40 0 ARQL
Emcee:  tuck Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
220[ß-Lapachone Prodrugs for Therapy Against Human Cancer Cells with Elevated tuck-4/19/2005
219ArQule at ASCO (5/15): finance.messages.yahoo.com Thanks to mh00034 for the dituck-4/15/2005
218<i>For every star like Genentech (Nasdaq: DNA), which is up 1,010% since 1FiloF-4/5/2005
217<i>Do not go where the path may lead; go instead where there is no path annigel bates-4/5/2005
216Returns That Defy the Imagination By John Reeves (TMF Bane) April 4, 2005 Do mopgcw-4/4/2005
215Just parking . . . unsure of relevance . . . >>[Cancer Research 65tuck-4/4/2005
214Preclinical Pipeline ARQ-550RP — E2F Modulation Applying our platformscaram(o)uche-3/16/2005
213up from 2,579,023 last proxy. (eom)scaram(o)uche-2/11/2005
2121 NAME OF REPORTING PERSON: Biotechnology Value Fund, L.P. I.R.S. IDENTIFICATIscaram(o)uche-2/11/2005
211ArQule Reports Fourth Quarter and Year End 2004 Financial Results Thursday Februmopgcw-2/11/2005
210Appreciate your impressions, thanks.keokalani'nui-2/10/2005
209Ph 1 inclusion criteria: "Histologically or cytologically confirmed solid tLee39-2/10/2005
208Wasn't an impressive CC by any means. I sold my position this morning. A couformer_pgs-2/10/2005
207ARQL earnings No big surprises. Hill did say 5 of 25 patients in ph 1 has stablLee39-2/10/2005
206fwiw; CIBC is dropping coverage of arql along with a number of other small caps.mopgcw-2/7/2005
205[Beta-Lapachone in Pancreatic Cancer; exploits NQO1] >>Cancer Biol Ther. tuck-1/31/2005
204No message. Sigh. EOM>keokalani'nui-1/26/2005
203ArQule Announces Enrollment of First Patient in Phase 1b/2 Combination Trial of Lee39-1/26/2005
202excerpt from Prospectus Supplement, January 24, 2005..... E2F Modulation scaram(o)uche-1/25/2005
201>> willowy, fetching, long-legged piece << cruel and unusual punnisscaram(o)uche-1/25/2005
200Yeah, and with the pre-pricing tank yesterday, Wall Street, same as it ever was.quidditch-1/25/2005
199Now we know why the price tanked yesterday. Sell at $6 with a guaranteed cover tthe hube-1/25/2005
198Nice, huh? A SIXTEEN PERCENT DISCOUNT to the 10 day average closing price. Wscaram(o)uche-1/25/2005
197ArQule to Raise Up to $31 Million Tuesday January 25, 7:15 am ET WOBURN, Mass.nigel bates-1/25/2005
196figures you're a biotech investor.scaram(o)uche-1/24/2005
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News